Article
Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic Cancer.
Anticancer research - 1 Nov 2024
Nakayama Hana, Ishida Hiroo, Iidaka Masanori, Kato Shoko, Nakatani Kei, Nakayama Akihiro, Noguchi Toshihiro, Nishihara Shigetoshi, Oikawa Shu, Usami Tomono, Mitsui Yuta, Ishii Y U, Toshima Hirokazu, Kobayashi Kouji, Murase Remi, Matsumoto Natsumi, Suzuki Kosuke, Shimada Ken, Yoshida Hitoshi, Fujita Ken-Ichi
Abstract excerpt
BACKGROUND/AIM: Nab-paclitaxel is used to treat patients with pancreatic cancer. However, it frequently induces peripheral neuropathy. Notably, pharmacokinetic factors may be associated with neuropathic symptoms as the onset depends on the cumulative dose. Therefore, we prospectively examined the association between the cumulative dose of nab-paclitaxel at the onset of peripheral neuropathy and polymorphisms of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
